COVISHIELD completes enrolment of Phase III clinical trials...

New Delhi [India], November 12 (ANI): The Serum Institute of India (SII) and Indian Council of Medical Research...

Brazil allows resumption of Chinese coronavirus vaccine trial

Ankara [Turkey], November 12 (ANI): Brazil's health regulator Anvisa on Wednesday (local time) announced the...

New analysis finds lung cancer screening reduces rates of...

Washington [US], November 11 (ANI): Low-dose CT screening methods may prevent one death per 250 at-risk adults...

China's COVID-19 vaccine trials suspended in Brazil after...

Brasilia [Brazil], November 10 (ANI): Brazil's health regulator Anvisa said on Monday it has suspended clinical...

Russian, Belarusian Prime Ministers discuss plans for Sputnik...

Moscow [Russia], November 6 (ANI/Sputnik): Russian Prime Minister Mikhail Mishustin and his Belarusian counterpart,...

AstraZeneca resumes US COVID-19 vaccine trial

London [UK], October 24 (ANI): The clinical trials for the AstraZeneca Oxford coronavirus vaccine -- AZD1222 -- have...

Dr Harsh Vardhan launches CuRED, CSIR partnered clinical...

New Delhi [India], October 21 (ANI): Union Health and Science and Technology Minister Dr Harsh Vardhan launched...

Expert panel recommends DCGI to permit Dr Reddy's Lab to...

New Delhi [India], October 17 (ANI): The expert committee of Drugs Controller General of India (DCGI) on Friday...

Therapy plus medication better than medication alone in...

Washington [US], October 15 (ANI): A review of 39 randomised clinical trials by scientists from UCLA and their...

Dr Reddy's Lab submits revised protocol to DCGI to conduct...

New Delhi [India], October 13 (ANI): Indian drug maker Dr Reddy's Laboratories (DRL) has submitted a revised...

DCGI directs Dr Reddy's lab to furnish fresh protocol to seek...

New Delhi [India], October 6 (ANI): In the latest development, the Drugs Controller General of India (DCGI) expert...

Dr Reddy's Laboratories seeks DCGI permission to conduct...

New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an...